This Activity Requires You To Leave myCME.

You are now leaving myCME and connecting to our educational partner. myCME does not control content, practices, or other policies of the site you are entering.

You are about to open a webpage that is outside of this educational content.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
This CME Activity has expired and is no longer available for credit.
Intervention & Prevention: Keeping Current with Acute Coronary Syndrome Journal Club (Issue #15)

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome Journal Club (Issue #15)

Format

Newsletter

Time to Complete

2.0 hours

Released

March 1, 2012

Expires

April 30, 2013

Program Description

Adding rivaroxaban to antiplatelet therapy post-ACS; role of vorapaxar in dual antiplatelet therapy; full prescription coverage post-MI improves medication adherence; increased bleeding risk with abciximab plus heparin vs. bivalirudin for PCI in NSTEMI patients.

Educational Objectives

After taking part in this educational activity, participants should be better able to:

  • Discuss current approaches to the management of patients with acute coronary syndrome (ACS), particularly those undergoing percutaneous coronary intervention (PCI)

  • Review the current guidelines of the American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions regarding use of dual antiplatelet therapy to prevent myocardial infarction (MI) and death in patients following PCI

  • Describe the concept of thienopyridine “resistance,” and explain its potential implications for secondary prevention in patients post-ACS

  • Evaluate emerging options for antiplatelet therapy post-ACS, including new thienopyridines, non-thienopyridines, and other agents, taking into consideration their safety, efficacy, and mechanisms of action

Disclosure

James A. de Lemos, MD, has received speakers’ honoraria from sanofi-aventis—Bristol-Myers Squibb partnership; consulting fees from AstraZeneca; and research grants from Roche Diagnostics.

Sandeep R. Das, MD, MPH, has no relevant relationships to disclose.

Michael C. Kontos, MD, has received honoraria from Astellas and AstraZeneca.

Accreditor Disclosures
E. Scott Monrad, MD,
has no relevant relationships to disclose.

The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine has nothing to disclose relative to this CME activity.

Publishing Staff Disclosures
Suzanne Bujara, Melissa Johnson,
and Anne Bardsley, Haymarket Medical Education, have nothing to disclose with regard to commercial support.

Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Albert Einstein College of Medicine of Yeshiva University, Daiichi Sankyo, Inc., Lilly USA, LLC, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine of Yeshiva University, Daiichi Sankyo, Inc., Lilly USA, LLC, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you have any questions relating to the accreditation of this activity, please contact Mildred Adighiuzor at 718-920-6674.

Faculty

PROGRAM CHAIR
James A. de Lemos, MD

Professor of Medicine
Cardiology Division
Southwestern Medical School
UT Southwestern Medical Center
Dallas, TX

EDITORIAL BOARD
Sandeep R. Das, MD, MPH

Assistant Professor
Donald W. Reynolds Cardiovascular Clinic Research Center
UT Southwestern Medical Center
Dallas, TX

Michael C. Kontos, MD
Associate Professor, Internal Medicine (Cardiology)
Pauley Heart Center
Virginia Commonwealth University
Richmond, VA

CME COURSE ADVISOR
E. Scott Monrad, MD

Professor of Clinical Medicine
Albert Einstein College of Medicine
Director, Cardiac Catheterization Laboratory
Einstein Division, Montefiore Medical Center
Bronx, NY

Accredited Provider

Sponsored by Albert Einstein College of Medicine of Yeshiva University




Commercial Supporter

Supported by an educational grant from Daiichi Sankyo, Inc., and Lilly USA, LLC.






Produced by Haymarket Medical Education

Intended Audience

Cardiologists, Primary Care Physicians

Credit

2.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of Albert Einstein College of Medicine of Yeshiva University and Haymarket Medical Education. Albert Einstein College of Medicine of Yeshiva University is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Albert Einstein Designates this enduring material for a maximum of 2.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Instructions

To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

Privacy Policy
To view the myCME privacy policy, please click here.

To view the privacy policy for Albert Einstein College of Medicine of Yeshiva University and Montefiore, please click here.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Add to Queue